🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Autofluorescence in Surgery for Primary Hyperparathyroidism

RecruitingNAAges 18 Years - anyAllAarhus University Hospital
NCT06230380 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims to test if autofluorescence imaging (AF) is a useful surgical aid during parathyroidectomy (PTX) for primary hyperthyroidism (PHPT).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age\>18 years and able to give informed consent. * A diagnosis of PHPT. * Planned exploratory PTX with ioPTH measurement. Exclusion Criteria: * Concordant high-confidence imaging; planned focused/selective PTX * Previous thyroid or parathyroid surgery. * Planned simultaneous thyroid surgery. * MEN, lithium induced hyperparathyroidism. * eGFR \< 30. * Kidney transplant.
💊

What it tests

  • Surgery with autofluorescence
📍

Where

1 site
Aarhus University Hospital
Aarhus, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy